LIQ001 + influenza vaccine

LIQ001 + influenza vaccine is an investigational combination immunization product comprising LIQ001, a novel agent, mixed with a commercially available seasonal influenza vaccine, designed to evaluate safety, tolerability, and immune response when both are administered together. The specific mechanism of action of LIQ001 is not publicly described, but as a combination, the product aims to induce protective immune responses to both the target(s) of LIQ001 and influenza viral antigens present in the seasonal vaccine. The mixture is being investigated as a co-formulation to potentially broaden or enhance influenza vaccine immunogenicity or provide additional immune benefit, details of which depend on the precise function of LIQ001[4].